Cargando…
Mechanisms of mutant β-catenin in endometrial cancer progression
Endometrial carcinoma (EC) is the most diagnosed gynecological malignancy in Western countries. Both incidence and mortality rates of EC have steadily risen in recent years. Despite generally favorable prognoses for patients with the endometrioid type of EC, a subset of patients has been identified...
Autores principales: | Parrish, Molly L., Broaddus, Russell R., Gladden, Andrew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556987/ https://www.ncbi.nlm.nih.gov/pubmed/36248967 http://dx.doi.org/10.3389/fonc.2022.1009345 |
Ejemplares similares
-
Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin
por: Liu, Chunhua, et al.
Publicado: (2019) -
Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling
por: Williams, Erin, et al.
Publicado: (2017) -
Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer
por: Deng, Lin, et al.
Publicado: (2020) -
Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer
por: Deng, Lin, et al.
Publicado: (2020) -
Wilms’ Tumor 1-Associated Protein Contributes to Chemo-Resistance to Cisplatin Through the Wnt/β-Catenin Pathway in Endometrial Cancer
por: Xie, Wenli, et al.
Publicado: (2021)